These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29916743)

  • 1. Advances in Care for Insulin-Requiring Patients Without Closed Loop.
    Lal RA; Buckingham B; Maahs DM
    Diabetes Technol Ther; 2018 Jun; 20(S2):S285-S291. PubMed ID: 29916743
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes.
    Welsh JB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S242-S249. PubMed ID: 29916736
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous Glucose Monitoring in 2017.
    Battelino T; Bode BW
    Diabetes Technol Ther; 2018 Feb; 20(S1):S13-S29. PubMed ID: 29437476
    [No Abstract]   [Full Text] [Related]  

  • 4. Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes.
    Ferrannini E
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):25-39. PubMed ID: 22575405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Glucose Monitoring in 2016.
    Bode BW; Battelino T
    Diabetes Technol Ther; 2017 Feb; 19(S1):S11-S18. PubMed ID: 28192020
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of automated insulin delivery technology in diabetes.
    Boughton CK; Hovorka R
    Diabetologia; 2024 Oct; 67(10):2034-2044. PubMed ID: 38740602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation.
    Wang J; Wang Z; Yu J; Kahkoska AR; Buse JB; Gu Z
    Adv Mater; 2020 Apr; 32(13):e1902004. PubMed ID: 31423670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closed-loop insulin delivery in type 1 diabetes.
    Thabit H; Hovorka R
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):105-17. PubMed ID: 22575409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closing the Loop.
    Nimri R; Audon P; Pinsker JE; Dassau E
    Diabetes Technol Ther; 2018 Feb; 20(S1):S41-S54. PubMed ID: 29437478
    [No Abstract]   [Full Text] [Related]  

  • 10. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 11. Handling Exercise During Closed Loop Control.
    Breton MD
    Diabetes Technol Ther; 2017 Jun; 19(6):328-330. PubMed ID: 28613948
    [No Abstract]   [Full Text] [Related]  

  • 12. Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend.
    Graf A; Ward GM; Vogrin S; Sundararajan V; Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Roy A; Jones TW; O'Neal DN
    Diabetes Technol Ther; 2017 Jul; 19(7):438-439. PubMed ID: 28537427
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin Pumps.
    Pickup JC
    Diabetes Technol Ther; 2018 Feb; 20(S1):S30-S40. PubMed ID: 29437475
    [No Abstract]   [Full Text] [Related]  

  • 14. The Hybrid Closed-Loop System: Evolution and Practical Applications.
    Weaver KW; Hirsch IB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S216-S223. PubMed ID: 29873517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Technology and the Human Factor.
    Liberman A; Barnard K
    Diabetes Technol Ther; 2018 Feb; 20(S1):S128-S138. PubMed ID: 29437474
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.
    Forlenza GP
    Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of Devices in Insulin Delivery.
    Meneghini LF; McNulty JN
    Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes.
    Dadlani V; Pinsker JE; Dassau E; Kudva YC
    Curr Diab Rep; 2018 Aug; 18(10):88. PubMed ID: 30159816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of Insulin Requirements in Adults with Type 2 Diabetes During Fully Closed-Loop Insulin Delivery.
    Lakshman R; Daly AB; Nwokolo M; Hartnell S; Wilinska ME; Cezar A; Evans ML; Hovorka R; Boughton CK
    Diabetes Technol Ther; 2023 Jun; 25(6):442-444. PubMed ID: 36971607
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin Requirements Over Eight Weeks of Fully Closed-Loop Insulin Delivery in Adults With Type 2 Diabetes.
    Lakshman R; Daly AB; Nwokolo M; Hartnell S; Wilinska ME; Cezar A; Evans ML; Hovorka R; Boughton CK
    J Diabetes Sci Technol; 2023 May; 17(3):868-870. PubMed ID: 36912020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.